Trial backs use of lenacapavir for pregnant, postpartum womentranslating…

Data from a phase 3 study assessing more than 5,000 women and 500 pregnancies support the use of long-acting lenacapavir as HIV pre-exposure prophylaxis among pregnant, postpartum and lactating women, researchers said.Lenacapavir (Yeztugo, Gilead) is administered via two…